Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E R Barrack

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
The Journal of Biological Chemistry|August 10, 1980
The specific binding of estrogens and androgens to the nuclear matrix of sex hormone responsive tissuesE R Barrack, D S Coffey
Journal of Steroid Biochemistry|January 1, 1987
Androgen receptor localization in the human prostate: demonstration of heterogeneity using a new method of steroid receptor autoradiographyC A Peters, E R Barrack
Cancer|June 15, 1991
Determination of growth fraction in advanced prostate cancer by Ki-67 immunostaining and its relationship to the time to tumor progression after hormonal therapyM V Sadi, E R Barrack
Cancer Research|June 15, 1995
Modulation of transforming growth factor beta 1 effects on prostate cancer cell proliferation by growth factors and extracellular matrixD M Morton, E R Barrack
Journal of Cellular Physiology|September 1, 1981
Mitogenesis in normal human fibroblasts by polyinosinic . polycytidylic acid and other synthetic acidic polymers: enhancement of action by glucocorticoidsE R Barrack, M D Hollenberg
Recent Progress in Hormone Research|January 1, 1982
Biological properties of the nuclear matrix: steroid hormone bindingE R Barrack, D S Coffey
The Journal of Urology|October 1, 1984
The relationship of androgen receptor levels to androgen responsiveness in the Dunning R3327 rat prostate tumor sublinesD A Diamond, E R Barrack
Molecular Endocrinology (Baltimore, Md.)|January 1, 1992
Transforming growth factor-beta 1 overproduction in prostate cancer: effects on growth in vivo and in vitroM S Steiner, E R Barrack
Cancer|April 15, 1993
Image analysis of androgen receptor immunostaining in metastatic prostate cancer. Heterogeneity as a predictor of response to hormonal therapyM V Sadi, E R Barrack
Cancer Research|March 1, 1983
Subcellular distribution of androgen receptors in human normal, benign hyperplastic, and malignant prostatic tissues: characterization of nuclear salt-resistant receptorsE R Barrack, P Bujnovszky, P C Walsh
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
The Journal of Biological Chemistry|August 10, 1980
The specific binding of estrogens and androgens to the nuclear matrix of sex hormone responsive tissuesE R Barrack, D S Coffey
Journal of Steroid Biochemistry|January 1, 1987
Androgen receptor localization in the human prostate: demonstration of heterogeneity using a new method of steroid receptor autoradiographyC A Peters, E R Barrack
Cancer|June 15, 1991
Determination of growth fraction in advanced prostate cancer by Ki-67 immunostaining and its relationship to the time to tumor progression after hormonal therapyM V Sadi, E R Barrack
Cancer Research|June 15, 1995
Modulation of transforming growth factor beta 1 effects on prostate cancer cell proliferation by growth factors and extracellular matrixD M Morton, E R Barrack
Journal of Cellular Physiology|September 1, 1981
Mitogenesis in normal human fibroblasts by polyinosinic . polycytidylic acid and other synthetic acidic polymers: enhancement of action by glucocorticoidsE R Barrack, M D Hollenberg
Recent Progress in Hormone Research|January 1, 1982
Biological properties of the nuclear matrix: steroid hormone bindingE R Barrack, D S Coffey
The Journal of Urology|October 1, 1984
The relationship of androgen receptor levels to androgen responsiveness in the Dunning R3327 rat prostate tumor sublinesD A Diamond, E R Barrack
Molecular Endocrinology (Baltimore, Md.)|January 1, 1992
Transforming growth factor-beta 1 overproduction in prostate cancer: effects on growth in vivo and in vitroM S Steiner, E R Barrack
Cancer|April 15, 1993
Image analysis of androgen receptor immunostaining in metastatic prostate cancer. Heterogeneity as a predictor of response to hormonal therapyM V Sadi, E R Barrack
Cancer Research|March 1, 1983
Subcellular distribution of androgen receptors in human normal, benign hyperplastic, and malignant prostatic tissues: characterization of nuclear salt-resistant receptorsE R Barrack, P Bujnovszky, P C Walsh
Pageof 4